Plant Comparison
Dill vs Pygeum
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Dill and Pygeum: they share 5 indicated uses (arthritis / joint pain, inflammation (general), skin irritation, …); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Dill | Pygeum | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 8/10 | 5/10 | Stronger for Dill |
| Inflammation (general) | 8/10 | 2/10 | Stronger for Dill |
| Skin irritation | 8/10 | 5/10 | Stronger for Dill |
| Urinary support | 8/10 | 10/10 | Stronger for Pygeum |
| Urinary tract infection (UTI) | 8/10 | 9/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Seed essential oil dominated by the monoterpene ketone carvone and limonene, giving dill its characteristic aroma and much of its carminative and antimicrobial activity.
Antioxidant flavonoids and phenolics identified in metabolomic analysis of leaf and seed extracts.
Pharmacological Actions
Anethum graveolens (dill) extract and essential oil induce ROS-mediated apoptosis in melanoma and lung adenocarcinoma cells (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Anethum graveolens (dill) extract induces ROS-mediated apoptosis in HT-144 melanoma cells, and its essential oil is selectively cytotoxic and pro-apoptotic against A549 lung adenocarcinoma cells (preclinical).
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
Safety, Cautions & Contraindications
Widely used as a food herb/spice; WHO monograph notes a “generally regarded as safe” status as a flavouring agent (World Health Organization, 2007). Allergic reactions (including oral itching, swelling, urticaria, vomiting/diarrhoea) are reported; avoid if you react to Apiaceae-family plants (World Health Organization, 2007; Egyptian Drug Authority, n.d.).
Duke (2002) provides clinical evidence (score 2) for dill's antibacterial and antispasmodic activities, consistent with Commission E and PhEur approvals. Traditional uses include management of colic, dyspepsia, and flatulence. The plant is a well-documented lactagogue (promotes milk production) and has a mild hypotensive effect. Dose: 1–3 g seeds as tea three times daily. Dill is generally safe (++) with no known significant contraindications at culinary and medicinal doses (Duke, 2002).
Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer. The evidence is mixed and rests on small, short, methodologically weak trials, so men with moderate or severe BPH should not rely on it instead of proven treatment.
Generally well tolerated, with mild gastrointestinal effects the most common report.
External Ids
Botanical Description
Aromatic annual herb with a slender, hollow, ridged, blue-green stem. The leaves are finely divided into thread-like segments, feathery and soft, similar to fennel but more delicate. Small yellow flowers are borne in flat, wide compound umbels at the stem tips in summer, ripening into flattened, ridged, aromatic seeds (fruits).[1]
Evergreen tree (Rosaceae), 10-30 m tall, with dark, fissured, red-brown bark (the source of the common name 'red stinkwood', from its unpleasant smell when cut). Leaves are glossy dark green, leathery, oblong with finely toothed margins. Small white, five-petalled flowers are borne in axillary racemes, followed by small reddish-brown, two-lobed fruit.
Habitat
Believed native to the eastern Mediterranean, Western Asia and southern Russia; widely cultivated as a culinary and medicinal herb in gardens and fields across Europe, Asia and the Americas.[1]
Native to montane forests of central and southern Africa (and Madagascar), growing at moderate to high altitude (roughly 900-3400 m). The species is CITES-listed and conservation-threatened owing to over-harvesting of bark for the pharmaceutical trade.
Harvesting
Leaves are picked fresh through the growing season; the seeds are harvested in late summer once the umbels have browned and dried, then threshed and dried further before storage.
Bark is traditionally stripped from mature trees. Unsustainable stripping - especially removing bark all the way round the trunk - kills the tree and has driven population decline, so sustainable, partial and rotational bark harvesting or cultivated sources are recommended.
Traditional Uses
Dill seed and leaf have a long culinary-medicinal history as a carminative digestive remedy for colic, dyspepsia and flatulence, and as a traditional lactagogue (galactagogue) to support breastfeeding; dill water ('gripe water') is a classic infant remedy for colic.[1]
Prunus africana bark has a traditional use in East and Central African ethnomedicine for urinary complaints, and its extract (marketed as Pygeum) became one of the most widely used European phytotherapy remedies for benign prostatic hyperplasia (BPH) symptoms in the 20th century. Clinical evidence for symptom benefit is moderate but drawn from small, methodologically weak trials.[11]
Preparations
The clinically studied commercial form, standardised for phytosterol content.
Dosage
The WHO monograph on Fructus Anethi gives an average daily dose of 3 g of the dried ripe fruit, or 0.1-0.3 g of the essential oil, or the equivalent in other preparations. Educational reference only, not a prescription.
Clinical trials have most often used around 100-200 mg/day of standardised lipophilic bark extract, divided into two doses. Educational reference only, not a prescription; any prostate or urinary symptom should be medically assessed first.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Thanuma, J., Phetcharaburanin, J., Dokduang, H., Loilome, W. and others (2025) 'Metabolomic analysis of bioactive compounds in dill (Anethum graveolens L.) extracts', PeerJ, 13, pp. e19567. doi:10.7717/peerj.19567 Preclinical
https://doi.org/10.7717/peerj.19567 - Sharma, H., Yang, H., Sharma, N. and An, S.S.A (2024) 'Neuroprotection by Anethum graveolens (Dill) Seeds and Its Phytocompounds in SH-SY5Y Neuroblastoma Cell Lines and Acellular Assays', International Journal of Molecular Sciences, 25(13), pp. 7104. doi:10.3390/ijms25137104 Preclinical
https://doi.org/10.3390/ijms25137104 - Mohammed, F.A., Elkady, A.I., Syed, F.Q., Mirza, M.B. and others (2018) 'Anethum graveolens (dill) - A medicinal herb induces apoptosis and cell cycle arrest in HepG2 cell line', Journal of Ethnopharmacology, 219, pp. 15-22. doi:10.1016/j.jep.2018.03.008 Preclinical
https://doi.org/10.1016/j.jep.2018.03.008 - Haidari, F., Zakerkish, M., Borazjani, F., Ahmadi Angali, K. and others (2020) 'The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes', Trials, 21(1), pp. 483. doi:10.1186/s13063-020-04401-3 Randomized trial
https://doi.org/10.1186/s13063-020-04401-3 - Li, Z., Xue, Y., Li, M., Guo, Q. and others (2018) 'The Antioxidation of Different Fractions of Dill (Anethum graveolens) and Their Influences on Cytokines in Macrophages RAW264.7', Journal of Oleo Science, 67(12), pp. 1535-1541. doi:10.5650/jos.ess18134 Preclinical
https://doi.org/10.5650/jos.ess18134 - Jang, S.A., Lee, S.J., Hwang, Y.H. and Ha, H (2023) 'Anti-Osteoporotic Potential of Water Extract of Anethum graveolens L. Seeds', Nutrients, 15(19), pp. 4302. doi:10.3390/nu15194302 Preclinical
https://doi.org/10.3390/nu15194302 - Stavri, M. and Gibbons, S (2005) 'The antimycobacterial constituents of dill (Anethum graveolens)', Phytotherapy Research, 19(11), pp. 938-941. doi:10.1002/ptr.1758 Preclinical
https://doi.org/10.1002/ptr.1758 - Orhan, I.E., Senol, F.S., Ozturk, N., Celik, S.A. and others (2013) 'Phytochemical contents and enzyme inhibitory and antioxidant properties of Anethum graveolens L. (dill) samples cultivated under organic and conventional agricultural conditions', Food and Chemical Toxicology, 59, pp. 96-103. doi:10.1016/j.fct.2013.05.053 Preclinical
https://doi.org/10.1016/j.fct.2013.05.053 - Tian, J., Ban, X., Zeng, H., He, J. and others (2012) 'The mechanism of antifungal action of essential oil from dill (Anethum graveolens L.) on Aspergillus flavus', PLoS One, 7(1), pp. e30147. doi:10.1371/journal.pone.0030147 Preclinical
https://doi.org/10.1371/journal.pone.0030147 - Castro, L.M., Pinto, N.B., Moura, M.Q., Villela, M.M. and others (2021) 'Antihelminthic action of the Anethum graveolens essential oil on Haemonchus contortus eggs and larvae', Brazilian Journal of Biology, 81(1), pp. 183-188. doi:10.1590/1519-6984.225856 Preclinical
https://doi.org/10.1590/1519-6984.225856 - World Health Organization (2007) 'Fructus Anethi'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Egyptian Drug Authority (n.d.). Available at: https://dev.edaegypt.gov.eg/media/a4kf0fmp/anethum-graveolens_1.pdf Traditional / reference
https://dev.edaegypt.gov.eg/media/a4kf0fmp/anethum-graveolens_1.pdf - Haidari, F., Mohammadshahi, M., Zarei, M., Gorji, Z., Asghari-Jafarabadi, M. and Alizadeh, M (2020) 'The effects of anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes'. doi:10.1016/j.ctim.2020.102367 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102367 - Mousavi, S.M., Pizarro, A.B., Akhgarjand, C., Bagheri, A., Persad, E., Karimi, E., Wong, A. and Jayedi, A (2022) 'The effects of Anethum graveolens (dill) supplementation on lipid profile and glycemic control: a systematic review and meta-analysis of randomized controlled trials', 62(21), pp. 5705--5716. doi:10.1080/10408398.2021.1889459 Meta-analysis / review
https://doi.org/10.1080/10408398.2021.1889459 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:837530-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:837530-1 - World Health Organization (2007) 'WHO monographs on selected medicinal plants, Volume 3: ‘Fructus Anethi'. Available at: https://e-lactancia.org/media/papers/Fitoterapia-Plantas-WHO-03_2007.pdf Traditional / reference
https://e-lactancia.org/media/papers/Fitoterapia-Plantas-WHO-03_2007.pdf - Aydogmus-Ozturk, F. and Jahan, H. and Ozturk, M. and Gunaydin, K. and Choudhary, M.I (2020) 'Preclinical study of the medicinal plants for the treatment of malignant melanoma', Molecular Biology Reports, 47(8), pp. 5975-5983. doi:10.1007/s11033-020-05671-5 Preclinical
https://doi.org/10.1007/s11033-020-05671-5 - Tavakkol Afshari, H.S. and Homayouni Tabrizi, M. and Ardalan, T. and Jalili Anoushirvani, N. and Mahdizadeh, R (2021) 'Anethum graveolens Essential Oil Nanoemulsions (AGEO-NE) as an Exclusive Apoptotic Inducer in Human Lung Adenocarcinoma (A549) Cells', Nutrition and Cancer, 74(4), pp. 1411-1419. doi:10.1080/01635581.2021.1952450 Preclinical
https://doi.org/10.1080/01635581.2021.1952450 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Washington State University Extension, Yakima County (2025) 'One Invasive, One Native, Both Deadly'. Available at: https://extension.wsu.edu/yakima/2025/08/09/one-invasive-one-native-both-deadly/ Traditional / reference
https://extension.wsu.edu/yakima/2025/08/09/one-invasive-one-native-both-deadly/ - King County Noxious Weeds (2024) 'Poison hemlock (Conium maculatum) identification and control'. Available at: https://kingcounty.gov/en/dept/dnrp/nature-recreation/environment-ecology-conservation/noxious-weeds/identification-control/poison-hemlock Traditional / reference
https://kingcounty.gov/en/dept/dnrp/nature-recreation/environment-ecology-conservation/noxious-weeds/identification-control/poison-hemlock - Dayan, A.D (2024) 'Death of Socrates: a likely case of poison hemlock (Conium maculatum) poisoning', Clinical Toxicology (Philadelphia, Pa.), 62(1), pp. 56-60. doi:10.1080/15563650.2024.2309328 Clinical study
https://doi.org/10.1080/15563650.2024.2309328 - Grow Forage Cook Ferment 'Poison Hemlock: How to Identify and Potential Look-alikes'. Available at: https://www.growforagecookferment.com/poison-hemlock/ Traditional / reference
https://www.growforagecookferment.com/poison-hemlock/
- Thompson, R.Q., Katz, D. and Sheehan, B (2019) 'Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health', Journal of Pharmaceutical and Biomedical Analysis, 163, pp. 162-169. doi:10.1016/j.jpba.2018.10.004 Preclinical
https://doi.org/10.1016/j.jpba.2018.10.004 - Dvorkin, L. and Song, K.Y (2002) 'Herbs for benign prostatic hyperplasia', The Annals of Pharmacotherapy, 36(9), pp. 1443-1452. doi:10.1345/aph.1A228 Meta-analysis / review
https://doi.org/10.1345/aph.1A228 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology, 22(Suppl 1), pp. 18-23. Meta-analysis / review
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Kim, T.H., Lim, H.J., Kim, M.S. and Lee, M.S (2012) 'Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews', Maturitas, 73(3), pp. 180-185. doi:10.1016/j.maturitas.2012.07.007 Meta-analysis / review
https://doi.org/10.1016/j.maturitas.2012.07.007 - Cambronero, J., Osca-Garcia, J.M., Merino-Salas, S., Miguel, J.M. and others (2022) 'Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)', Archivos Espanoles de Urologia, 75(3), pp. 219-227. Clinical study
https://scholar.google.com/scholar?q=Effectiveness%20of%20treatment%20with%20Pygeum%20africanum%20in%20patients%20with%20lower%20urinary%20tract%20symptoms%20and%20benign%20prostatic%20hyperplasia%3A%20a%20cross-sectional%20study%20in%20the%20real-world%20clinical%20practice%20in%20Spain%20%28The%20PROFIT%20Study%29 - Quiles, M.T., Arbos, M.A., Fraga, A., de Torres, I.M. and others (2010) 'Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)', The Prostate, 70(10), pp. 1044-1053. doi:10.1002/pros.21138 Preclinical
https://doi.org/10.1002/pros.21138 - Salinas-Casado, J., Esteban-Fuertes, M., Carballido-Rodriguez, J. and Cozar-Olmo, J.M (2020) 'Review of the experience and evidence of Pygeum africanum in urological practice', Actas Urologicas Espanolas, 44(1), pp. 9-13. doi:10.1016/j.acuro.2019.08.002 Meta-analysis / review
https://doi.org/10.1016/j.acuro.2019.08.002 - Villar, A., Silva-Fuentes, F., Mula, A. and Zangara, A (2024) 'Anti-Inflammatory Potential of Prunus africana Bark Extract: An In Vitro Study of Cytokine Release by Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells', International Journal of Molecular Sciences, 25(15), pp. 8298. doi:10.3390/ijms25158298 Preclinical
https://doi.org/10.3390/ijms25158298 - Larre, S., Camparo, P., Comperat, E., Boulbes, D. and others (2012) 'Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures', Asian Journal of Andrology, 14(3), pp. 499-504. doi:10.1038/aja.2011.132 Preclinical
https://doi.org/10.1038/aja.2011.132 - Rubegeta, E., Makolo, F., Kamatou, G., Enslin, G. and others (2023) 'The African cherry: A review of the botany, traditional uses, phytochemistry, and biological activities of Prunus africana (Hook.f.) Kalkman', Journal of Ethnopharmacology, 305, pp. 116004. doi:10.1016/j.jep.2022.116004 Meta-analysis / review
https://doi.org/10.1016/j.jep.2022.116004 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology. Randomized trial
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Dedhia, R.C. and McVary, K.T (2008) 'Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia', The Journal of Urology, 179(6), pp. 2119--2125. doi:10.1016/j.juro.2008.01.094 Meta-analysis / review
https://doi.org/10.1016/j.juro.2008.01.094 - Wilt, T. and Ishani, A. and Mac Donald, R. and Rutks, I. and Stark, G (2002) 'Pygeum africanum for benign prostatic hyperplasia', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001044 Meta-analysis / review
https://doi.org/10.1002/14651858.CD001044
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.